1 Yokoi H,Daida H,Kuwabara Y,et al.Effective-ness of an antioxidation in preventing restenosis after PTCA:the probucol angioplasty restenosistrial.J Am Coll Cardiol,1997;30855
2 Watanabe K,Sekiva M,Ikeda S,et al.Preventive effects of probucol on restenosis after percutane ous transluminal coronary angioplasty.Am Heart J,1996;132:23
3 RodesJ,Cote G,LesPerance J,et al.Prevention of restenosisafter angioplasty in small coronary arteries with probucol.Circulation,1998;97:429
4 Sekiya M,Funada J,Watanabe K,et al.Effectsof probucol and cilostazol alone and in combination on frequency of poststenting restenosis.Am J Cardiol,1998;82:144
5 Cote G,Tardif JC,LesPerance J,et al.Effects of probucol on vascular remodeling after coronary angioplasty.Circulation,1999;99:30
6 Topol EJ,Califf RM,Weismann HF,et al.Randomisedtrial of coronary intervention with antibody against plateletIIb/lIaintegrin for reduction of clinical restenosis:results at six months.Lancet,1994;343:881
7 The EPIC inv estigators.Use of monoclonal antibody directed against the platelet glyoproteinIIb/ Ilareceptor in high risk coronary angioplasty.N Engl J Med,1994;330956
8 Ferguson JJ,Kereiakes DJ,Adgey J,et al.Safe use of platelet GP II b/IIa inhibitor.Am Heart J,1998;135s77
9 Gibson CM,Goel M,Cohen DJ,et al.Six month angiographic and clinical follow up patients prospec-tively randomized to receive either tirofiban or placebo during angioplasty in the RES TORE trial.J Am Coll Cardiol,199832:28
10 The ERASE R investigators.Acute platelet inhibi-tion with abciximab does not reduce in stent restenosis (ERASER study).Circulation,1999;100799
11 Ueda Y,Kitakaze M,Imakita M,et al.Glycoprotein IIb/IIa antagonist FK633 could not prevent neointimal thickening in stent implantation m odel of canine coronary artery.A rteriosder Thromb Vasc Biol,1999;19:343
12 Haase KK,M ahrholdt H,Schroder S,et al.Fre-quency and efficiency of glycoprotein II b/ Illa ther -apyfortreatment of the threatened or acute vessel closure in 1332 patients under going percutaneous transluminal coronary angioplasty.Am Heart J,1999;137:234
13 Marijianowski MM,Nakada MT,Sundell BI,et al.A bciximab reduces vascular lesion for mationin non -human Primates.J Am Coll Cardiol,1999(suppl):8451.69A
14 Okamoto S,Inden M,Setsuda M,et al.Effects of trapidil(t riazlopy rimidine),a platelet derived growth factor antagonist in preven ting restenosis after PT-CA.Am Heart J,1992;123:1439
15 Nishikawa H,Ono N,Motoyasu M,et al.Preventive effects of trapidil on restenosis after percutaneous transluminal oronary angioplasty.Circulation,1992;86:I一53(abstr)
16 Maresta A,Balducelli M,Cantini L,et al.Trapidil(triazolopy rimidine),a platelet derived growth fac -tor antagonist,reduces restenosis after percutaneo us transluminal coronary angioplasty.Circulation,1994;902710
17 Yasue H,Ogawa H,Tanaka H,et al.Effects of aspirin and trapidil on cardiovascular events after acute my ocardial infarction.Am J Cardiol,1999;83:1308
18 M iyazawa K,Fukuyama J,Misawa K,et al.Trani last antagonizes angiotensin II and inhibitsits bio -logical effects in vascu larsmooth muscle cells.A therosclerosis,1996;121:167
19 Tanaka K,Honda M,Kuramochi T,et al.Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth musclecells.A therosclerosis,1994;107:179
20 Ueda K,Tamai H,Hsu YS,et al.Efficacy of trani-last on restenosis after coronary angioplasty:is there any rebound phenomenon after ceasing tranilast at three months? J Am Coll Cardiol,1995;25:225A(abstr)
21 Ishibashi S,lkeda U,Lhara T,et al.Tranilast in-hibits contraction and Ca2+mo vement of por cine coronary arteries.A therosclerosis,1997;130:113
22 M iyazawa K,Fukuyama J,Misawa K,et al.Trani -last antagonizes angiotensin II and inhibits its bio-logical effects in vascular smooth musde cells.A the rosclerosis,1996;121:167
23 Word MR,Sasahara T,Agrotis A,et al.Inhibitory effects of tranilast on expression of transforming growth factorp isforms and receptors in injured arte ries.A therosderosis,1998;137:267
24 Kusama H,Kikuchi S,TazawaS,et al.Tranilast in -hibits the proliferation of human coronary smooth muscle cell through the activation of P21 wafl.A therosclerosis,1999;143307
25 Burke SE,Lubbery NL,Chen YW,et al.Neointi -mal formation after ballon induced vascular injury in yucatan minipigs is reduced by oral rapamyin.J Cardiov asc Pharmacol,1999;33829
26 Marx SO,Jayaraman T,Go LO,et al.Rapamyein FK BP inhibits cell cyde regulators of proliferation in vascular smooth muse cells.Cire Res,1995;76:412
27 Gallo R,Padurean A,Jayaraman T,et al.Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.Girculation,1999;99:2164
28 Gray TJ,Strauss BH,Hinek A.Inhibitory mechanisms by which suramin may attenuate neointimal for mation after balloon angioplasty.J Cardiovasc Pharmcol,1999,33:960
29 Hu Y,Zou Y,Dietrich H,et al.Inhibition of neointi-mal hyperplasia of mouse vein grafts by locallyap.plied suramine.Circulation,1999;100:861
30 Nagler A,Miao HQ,Aingorn H,et al.Inhibition of collagen synthesis,vascular smooth muscle cells pro -liferation,and injury induced intimal hyperplasia by halofuginone.Arterioscler Thromb Vasc Biol,1997;17:194
31 YasunariK,Kohino M,Hasuma T,et al.Dopamine as a noval antimigration and antiproliferative factor of vascular smooth muscle cells through dopamine D1 tike receptors.Arterioscler Thromb Vase Biol,1997;17:3164. |
